1. My Last Issue—a Farewell to Cardiovascular Drugs and Therapy

   • Willem J. Remme

   Editorial 18 December 2019 Pages: 641 - 643

   

2. The Role of Nav1.8 in Cardiac Electrophysiology—a Matter of the Heart or the Nerve?

   • Katja E. Odening

   Invited Editorial 18 January 2020 Pages: 645 - 647

3. Absence of Functional Na_v1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes

   • Simona Casini
   • Gerard A. Marchal
   • Carol Ann Remme

   Original Article Open access 08 January 2020 Pages: 649 - 660

   

4. Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide

   • Maryna V. Basalay
   • Sean M. Davidson
   • Derek M. Yellon

   ORIGINAL ARTICLE Open access 13 November 2019 Pages: 661 - 667

   

5. The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart

   • Mitchel Tate
   • Gavin C. Higgins
   • Rebecca H. Ritchie

   SHORT COMMUNICATION Open access 25 October 2019 Pages: 669 - 674

   

6. LncRNA MALAT1 Promotes Oxygen-Glucose Deprivation and Reoxygenation Induced Cardiomyocytes Injury Through Sponging miR-20b to Enhance beclin1-Mediated Autophagy

   • Shuang Wang
   • Tao Yao
   • Zhihua Ruan

   ORIGINAL ARTICLE 10 December 2019 Pages: 675 - 686

   

7. A Novel Epigenetic Drug-Eluting Balloon Angioplasty Device: Evaluation in a Large Animal Model of Neointimal Hyperplasia

   • HongBin Liu
   • Melissa Byrne
   • Anthony E. Dear

   Short Communication 30 December 2019 Pages: 687 - 692

   

8. Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure

   • Jasmine A. Luzum
   • Christopher Ting
   • David E. Lanfear

   ORIGINAL ARTICLE 14 November 2019 Pages: 693 - 700

   

9. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis

   • Yi-Hsin Chan
   • Hsin-Fu Lee
   • Gregory Y. H. Lip

   REVIEW ARTICLE 19 November 2019 Pages: 701 - 710

   

10. Omitting aspirin in PCI patients: Myth or reality?

    • Dimitrios Alexopoulos
    • Aikaterini Mpahara
    • George Kassimis

    REVIEW ARTICLE 06 December 2019 Pages: 711 - 724

    

11. Drug-Induced Pulmonary Arterial Hypertension: Mechanisms and Clinical Management

    • Michele Correale
    • Lucia Tricarico
    • Natale Daniele Brunetti

    Review Article 06 December 2019 Pages: 725 - 738

    

12. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives

    • M. F. Wu
    • K. Z. Xu
    • L. M. Lin

    REVIEW ARTICLE 26 October 2019 Pages: 739 - 748

13. Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown

    • Victor Gurewich

    Review Article 02 January 2020 Pages: 749 - 753

    

14. The Effect of Ranolazine on Glycemic Control: a Narrative Review to Define the Target Population

    • Dusty Lisi
    • Ebony Andrews
    • Hua Ling

    Review Article 04 December 2019 Pages: 755 - 761

15. Prediabetes with Hypertension and Dyslipidemia: Are They Triad of Future Cardiovascular Risk?

    • Venu Gopal Jonnalagadda

    LETTER TO THE EDITOR 13 October 2018 Pages: 763 - 763

16. Response Letter to Letter by Venu Jonnalagadda

    • Jun Tao

    LETTER TO THE EDITOR 08 August 2019 Pages: 765 - 766

17. Activation of T Lymphocytes as a Novel Mechanism in Beta1-Adrenergic Receptor Autoantibody-Induced Cardiac Remodeling—Additional Information About TLR9 Involvement

    • Annekathrin Haberland
    • Johannes Müller
    • Katrin Wenzel

    LETTER TO THE EDITOR Open access 18 March 2019 Pages: 767 - 768